From: Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study
Features | Patients |
---|---|
Gender | |
 Males | 62 |
 Females | 26 |
Asbestos exposure | |
 Work | 26 |
 Environmental | 32 |
 None | 30 |
Smoking habit | |
 Never | 36 |
 Active smokers | 15 |
 Past smokers | 37 |
Radiologic findings | |
 Pleural effusion | 84 |
 Bilateral alterations | 34 |
 Mediastinal involvment | 34 |
 Diaphragm involvement | 45 |
Diagnostic approach | |
 Medical thoracoscopy | 50 |
 VATS | 19 |
 CT-guided biopsy | 19 |
Histology | |
 Epitheliod | 66 |
 Sarcomatoid | 6 |
 Biphasic | 7 |
 NOS | 9 |
Disease stage (TNM) | |
 I | 37 |
 II | 30 |
 IIIA | 5 |
 IIIB | 9 |
 IV | 7 |
Therapy | |
 Surgery | |
  P/D | 46 |
  Palliative surgery | 6 |
 Chemotherapy | |
  I line | |
   Platinum-pemetrexed | 67 |
   Monochemotherapy | 18 |
  II line | 52 |
   Gemcitabine | 30 |
   Vinorelbine | 19 |
   Re-challenge | 3 |
  Radiotherapy | |
   Debulking | 3 |
   Palliative | 4 |
Outcome | Months |
 PFS | 9.8 |
 OS | 15.6 |